449 related articles for article (PubMed ID: 27387377)
1. Bioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In Vitro.
Nguyen DG; Funk J; Robbins JB; Crogan-Grundy C; Presnell SC; Singer T; Roth AB
PLoS One; 2016; 11(7):e0158674. PubMed ID: 27387377
[TBL] [Abstract][Full Text] [Related]
2. A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity.
Kostadinova R; Boess F; Applegate D; Suter L; Weiser T; Singer T; Naughton B; Roth A
Toxicol Appl Pharmacol; 2013 Apr; 268(1):1-16. PubMed ID: 23352505
[TBL] [Abstract][Full Text] [Related]
3. Editor's Highlight: Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional Bioprinted Human Liver Tissues.
Norona LM; Nguyen DG; Gerber DA; Presnell SC; LeCluyse EL
Toxicol Sci; 2016 Dec; 154(2):354-367. PubMed ID: 27605418
[TBL] [Abstract][Full Text] [Related]
4. 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies.
Mueller D; Krämer L; Hoffmann E; Klein S; Noor F
Toxicol In Vitro; 2014 Feb; 28(1):104-12. PubMed ID: 23850736
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity evaluation using cryopreserved primary human hepatocytes in various culture formats.
Richert L; Baze A; Parmentier C; Gerets HHJ; Sison-Young R; Dorau M; Lovatt C; Czich A; Goldring C; Park BK; Juhila S; Foster AJ; Williams DP
Toxicol Lett; 2016 Sep; 258():207-215. PubMed ID: 27363785
[TBL] [Abstract][Full Text] [Related]
6. Mimicking Native Liver Lobule Microarchitecture In Vitro with Parenchymal and Non-parenchymal Cells Using 3D Bioprinting for Drug Toxicity and Drug Screening Applications.
Janani G; Priya S; Dey S; Mandal BB
ACS Appl Mater Interfaces; 2022 Mar; 14(8):10167-10186. PubMed ID: 35171571
[TBL] [Abstract][Full Text] [Related]
7. Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting.
Ma X; Qu X; Zhu W; Li YS; Yuan S; Zhang H; Liu J; Wang P; Lai CS; Zanella F; Feng GS; Sheikh F; Chien S; Chen S
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2206-11. PubMed ID: 26858399
[TBL] [Abstract][Full Text] [Related]
8. 3D hepatic cultures simultaneously maintain primary hepatocyte and liver sinusoidal endothelial cell phenotypes.
Kim Y; Rajagopalan P
PLoS One; 2010 Nov; 5(11):e15456. PubMed ID: 21103392
[TBL] [Abstract][Full Text] [Related]
9. Morphological and Functional Characterization and Assessment of iPSC-Derived Hepatocytes for In Vitro Toxicity Testing.
Lu J; Einhorn S; Venkatarangan L; Miller M; Mann DA; Watkins PB; LeCluyse E
Toxicol Sci; 2015 Sep; 147(1):39-54. PubMed ID: 26092927
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes.
Terelius Y; Figler RA; Marukian S; Collado MS; Lawson MJ; Mackey AJ; Manka D; Qualls CW; Blackman BR; Wamhoff BR; Dash A
Chem Biol Interact; 2016 Aug; 255():31-44. PubMed ID: 26626330
[TBL] [Abstract][Full Text] [Related]
11. Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing.
Tostões RM; Leite SB; Serra M; Jensen J; Björquist P; Carrondo MJ; Brito C; Alves PM
Hepatology; 2012 Apr; 55(4):1227-36. PubMed ID: 22031499
[TBL] [Abstract][Full Text] [Related]
12. A novel evaluation method for determining drug-induced hepatotoxicity using 3D bio-printed human liver tissue.
Ide I; Nagao E; Kajiyama S; Mizoguchi N
Toxicol Mech Methods; 2020 Mar; 30(3):189-196. PubMed ID: 31736396
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha.
Shaw PJ; Hopfensperger MJ; Ganey PE; Roth RA
Toxicol Sci; 2007 Nov; 100(1):259-66. PubMed ID: 17709330
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes.
Ware BR; Berger DR; Khetani SR
Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675
[TBL] [Abstract][Full Text] [Related]
15. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.
Rubiano A; Indapurkar A; Yokosawa R; Miedzik A; Rosenzweig B; Arefin A; Moulin CM; Dame K; Hartman N; Volpe DA; Matta MK; Hughes DJ; Strauss DG; Kostrzewski T; Ribeiro AJS
Clin Transl Sci; 2021 May; 14(3):1049-1061. PubMed ID: 33382907
[TBL] [Abstract][Full Text] [Related]
16. A human liver organoid screening platform for DILI risk prediction.
Zhang CJ; Meyer SR; O'Meara MJ; Huang S; Capeling MM; Ferrer-Torres D; Childs CJ; Spence JR; Fontana RJ; Sexton JZ
J Hepatol; 2023 May; 78(5):998-1006. PubMed ID: 36738840
[TBL] [Abstract][Full Text] [Related]
17. Current limitations and future opportunities for prediction of DILI from in vitro.
Funk C; Roth A
Arch Toxicol; 2017 Jan; 91(1):131-142. PubMed ID: 27766365
[TBL] [Abstract][Full Text] [Related]
18. Co-culture of Hepatocytes and Kupffer Cells as an In Vitro Model of Inflammation and Drug-Induced Hepatotoxicity.
Rose KA; Holman NS; Green AM; Andersen ME; LeCluyse EL
J Pharm Sci; 2016 Feb; 105(2):950-964. PubMed ID: 26869439
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
Utkarsh D; Loretz C; Li AP
Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
[TBL] [Abstract][Full Text] [Related]
20. Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury.
Proctor WR; Foster AJ; Vogt J; Summers C; Middleton B; Pilling MA; Shienson D; Kijanska M; Ströbel S; Kelm JM; Morgan P; Messner S; Williams D
Arch Toxicol; 2017 Aug; 91(8):2849-2863. PubMed ID: 28612260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
